Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
Clinical trial NCT05639933 · RECRUITING
Trial details
- NCT number
- NCT05639933
- Sponsor
- Hoth Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-19
- Primary completion
- 2026-12-30
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.